BDH Industries Limited — Erythromycin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Erythromycin · $850.0K export value · DGFT Verified
BDH Industries Limited is the #2 Indian exporter of Erythromycin with $850.0K in export value and 17 verified shipments. BDH Industries Limited holds a 1.1% market share in Erythromycin exports across 7 countries. The company exports 13 pharmaceutical products worth $5.7M across 9 therapeutic categories.
BDH Industries Limited — Erythromycin Export Profile: Buyers & Destinations
Where Does BDH Industries Limited Export Erythromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $200.0K | 4 | 68.0% |
| CHILE | $50.0K | 1 | 17.0% |
| MOZAMBIQUE | $24.8K | 3 | 8.4% |
| PAPUA NEW GUINEA | $10.0K | 1 | 3.4% |
| TONGA | $5.6K | 4 | 1.9% |
| AUSTRALIA | $2.5K | 3 | 0.9% |
| MADAGASCAR | $1.1K | 1 | 0.4% |
BDH Industries Limited exports Erythromycin to 7 countries. The largest destination is PHILIPPINES accounting for 68.0% of BDH Industries Limited's Erythromycin shipments, followed by CHILE (17.0%) and MOZAMBIQUE (8.4%). These destinations reflect BDH Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Erythromycin from BDH Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NELPA LIFESCIENCES INC | PHILIPPINES | $200.0K | 4 |
| BPH S A | CHILE | $50.0K | 1 |
| M/S, PROFARMA LDA | MOZAMBIQUE | $14.2K | 2 |
| M SPROFARMA LDA AV OLOF PALM | MOZAMBIQUE | $10.6K | 1 |
| BORNEO PACIFIC PHARMACEUTICALS LTD, | PAPUA NEW GUINEA | $10.0K | 1 |
| M/S.SOUTH AUSTRAL PTY LTD | TONGA | $5.6K | 4 |
| SOUTH AUSTRAL PTY LTD | AUSTRALIA | $1.8K | 1 |
| SALAMA,CENTRALE D' ACHATS DE MEDICA | MADAGASCAR | $1.1K | 1 |
| M/S,SOUTH AUSTRAL PTY LTD | AUSTRALIA | $697 | 2 |
BDH Industries Limited supplies Erythromycin to 9 buyers globally. The largest buyer is NELPA LIFESCIENCES INC (PHILIPPINES), followed by BPH S A (CHILE) and M/S, PROFARMA LDA (MOZAMBIQUE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Erythromycin Export Value and How Much Does BDH Industries Limited Contribute?
India exported $19.0M worth of Erythromycin through 3,939 shipments from 368 suppliers to 135 countries, serving 992 buyers globally. BDH Industries Limited contributes $850.0K to this total, accounting for 1.1% of India's Erythromycin exports. BDH Industries Limited ships Erythromycin to 7 countries through 9 buyers.
What Is the Average Shipment Value for BDH Industries Limited's Erythromycin Exports?
BDH Industries Limited's average Erythromycin shipment value is $50.0K per consignment, based on 17 shipments totaling $850.0K. The largest destination is PHILIPPINES (68.0% of BDH Industries Limited's Erythromycin exports).
How Does BDH Industries Limited Compare to Other Indian Erythromycin Exporters?
BDH Industries Limited ranks #2 among 368 Indian Erythromycin exporters with a 1.1% market share. The top 3 exporters are MEDOPHARM ($3.0M), S KANT HEALTHCARE LIMITED ($2.8M), MEDREICH LIMITED ($2.1M). BDH Industries Limited processed 17 shipments to 7 destination countries.
What Erythromycin Formulations Does BDH Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ERYSAPH T500 Erythromycin Stearate Tablets USP 500mg Batch No NER 31 9900x10x10 T | $50.0K | 1 |
| ERYSAPH T500 (Erythromycin Stearate Tabl | $50.0K | 1 |
| ERYTHROMYCIN ETHYL SUCCINATE FILM COATEDTABLETS 500 MG | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, ASCORSAPH-ERYSAPH T 500 (ERYTHROMYCINSTEARATE TABLETS USP 500 MG)(PACK OF 10 | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, ERYSAPH T500 (ERYTHROMYCIN STEARATE TABLETS USP 500 MG) | $50.0K | 1 |
| Erythromycin Stearate Tablets BP 500mg ERYC - S-500 Batch No.0308231500X10X10T | $10.6K | 1 |
| ERYTHROMYCIN STEARATE TABLETS BP 500MG (ERYC - S-500) (BATCH NO.101123)(1500X10X10T) | $10.6K | 1 |
| ERYTHROMYCIN STEARATE TABLET BP 250 MG(E | $10.0K | 1 |
| ERYTHROMYCIN ETHYL SUCCINATE FOR ORAL S | $4.0K | 2 |
| Erythromycin Stearate Tablets BP 500mg ( | $3.6K | 1 |
BDH Industries Limited exports 15 distinct Erythromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERYSAPH T500 Erythromycin Stearate Tablets USP 500mg Batch N with 1 shipments worth $50.0K.
How Does BDH Industries Limited Compare to Nearest Erythromycin Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | CAPLIN POINT LABORATORIES LIMITED | $1.2M | 24 | 4 | $50.0K |
| 13 | S K AGE EXPORTS | $1.1M | 54 | 7 | $20.8K |
| 2 | BDH INDUSTRIES LIMITED ★ | $850.0K | 17 | 7 | $50.0K |
| 12 | SIDHAANT LIFE SCIENCES PRIVATE LIMITED | $750.0K | 15 | 6 | $50.0K |
| 14 | GLOBELA PHARMA PRIVATE LIMITED | $750.0K | 15 | 2 | $50.0K |
BDH Industries Limited ranks #2 among 368 Indian Erythromycin exporters. Average shipment value of $50.0K compared to the market average of $51.7K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and S K AGE EXPORTS.
Which Indian Ports Ship Erythromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 13.0% |
| DELHI AIR CARGO ACC (INDEL4) | 394 | 10.0% |
| SAHAR AIR | 377 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 370 | 9.4% |
| JNPT/ NHAVA SHEVA SEA | 234 | 5.9% |
| DELHI AIR | 227 | 5.8% |
| JNPT | 176 | 4.5% |
| Bombay Air | 99 | 2.5% |
What Other Antibiotics Products Does BDH Industries Limited Export?
BDH Industries Limited also exports these antibiotics products. Each links to the detailed product page.
About BDH Industries Limited
BDH Industries Limited exports 13 products worth $5.7M. Beyond Erythromycin, top products include Vitamin, Celecoxib, Tetracycline, Carvedilol, Zinc. View the complete BDH Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erythromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erythromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: BDH Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 17 individual customs records matching BDH Industries Limited exporting Erythromycin, covering 15 formulations to 7 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 135+ countries, 992+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erythromycin Export Data from BDH Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for BDH Industries Limited's Erythromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BDH Industries Limited
Full Company Profile →
13 products · $5.7M total trade · 9 categories
Erythromycin Stats
Company Overview
Top Products by BDH Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for BDH Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erythromycin. For current shipment-level data, contact TransData Nexus.